Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05739123 · ClinicalTrials.gov registry record
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
A clinical trial of Pregnancy Related and Pregnancy Complications, sponsored by Sumitomo Pharma Switzerland.
- Recruiting
- Registry status
- 728
- Enrollment target
- 1
- Study location
NCT05739123 is a study of Pregnancy Related and Pregnancy Complications that is actively recruiting participants, run by Sumitomo Pharma Switzerland. The registered enrollment target is 728 participants, below the 1,956-participant average among 99 other Pregnancy Related trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05739123, a study of Pregnancy Related and Pregnancy Complications, is actively recruiting participants, sponsored by Sumitomo Pharma Switzerland.
- RECRUITING
- Registry status
- 728 participants
- Enrollment target
- 1
- Study location
Study Summary
The Relugolix Pregnancy Registry is a prospective, observational cohort study designed to evaluate the association between relugolix-containing therapy exposure during pregnancy and subsequent maternal, fetal, and infant outcomes. Data will be collected from enrolled pregnant women and the healthcare providers (HCPs) involved in their care or the care of their infants, if applicable.
Conditions Studied
Interventions
- DRUG Relugolix-Containing Product
Study Locations (1)
North Carolina
- PPD - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 728 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2033-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05739123
The ClinicalTrials.gov registry entry for NCT05739123 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 728 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,956-participant average among 99 other Pregnancy Related trials with a reported enrollment target (63% lower). The listed sponsor is Sumitomo Pharma Switzerland, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Relugolix-Containing Product is the first listed.
NCT05739123 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05739123 about?
NCT05739123 is a clinical study titled "Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring". The Relugolix Pregnancy Registry is a prospective, observational cohort study designed to evaluate the association between relugolix-containing therapy exposure during pregnancy and subsequent maternal, fetal, and infant outcomes. Data will be collected from enrolled pregnant women and the healthcar...
What is the current status of trial NCT05739123?
This trial is currently recruiting. The enrollment target is 728 participants. The study started on 2023-05-08. Estimated completion is 2033-05.
What conditions does trial NCT05739123 study?
This clinical trial studies the following conditions: Pregnancy Related, Pregnancy Complications, Pregnancy, High Risk.
What interventions are being tested in trial NCT05739123?
The interventions under investigation include: Relugolix-Containing Product (DRUG).
Who is sponsoring clinical trial NCT05739123?
This trial is sponsored by Sumitomo Pharma Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05739123 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.